Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PGA2 | cPLA2i | 1.0 | BCD110605C16 | 0.013 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 1.0 | BCD110605C18 | 0.029 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 1.0 | BCD110605C17 | 0.045 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 4.0 | BCD110605C34 | 0.016 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 4.0 | BCD110605C36 | 0.03 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 4.0 | BCD110605C35 | 0.011 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 20.0 | BCD110605C53 | 0.021 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 20.0 | BCD110605C54 | 0.025 | pmol/ml of medium |
| - | PGA2 | cPLA2i | 20.0 | BCD110605C52 | 0.073 | pmol/ml of medium |
| - | PGA2 | PLDi | 1.0 | BCD110605C10 | 0.019 | pmol/ml of medium |
| - | PGA2 | PLDi | 1.0 | BCD110605C12 | 0.023 | pmol/ml of medium |
| - | PGA2 | PLDi | 1.0 | BCD110605C11 | 0.06 | pmol/ml of medium |
| - | PGA2 | PLDi | 4.0 | BCD110605C30 | 0.017 | pmol/ml of medium |
| - | PGA2 | PLDi | 4.0 | BCD110605C29 | 0.02 | pmol/ml of medium |
| - | PGA2 | PLDi | 4.0 | BCD110605C28 | 0.041 | pmol/ml of medium |
| - | PGA2 | PLDi | 20.0 | BCD110605C48 | 0.043 | pmol/ml of medium |
| - | PGA2 | PLDi | 20.0 | BCD110605C47 | 0.022 | pmol/ml of medium |
| - | PGA2 | PLDi | 20.0 | BCD110605C46 | 0.017 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 1.0 | BCD110605C19 | 0.133 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 1.0 | BCD110605C21 | 0.083 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 1.0 | BCD110605C20 | 0.093 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 4.0 | BCD110605C39 | 0.167 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 4.0 | BCD110605C37 | 0.241 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 4.0 | BCD110605C38 | 0.201 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 20.0 | BCD110605C55 | 1.22 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 20.0 | BCD110605C57 | 1.56 | pmol/ml of medium |
| - | PGA2 | KDO+cPLA2i | 20.0 | BCD110605C56 | 1.5 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 1.0 | BCD110605C15 | 0.061 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 1.0 | BCD110605C14 | 0.078 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 1.0 | BCD110605C13 | 0.104 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 4.0 | BCD110605C32 | 0.572 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 4.0 | BCD110605C31 | 0.617 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 4.0 | BCD110605C33 | 0.664 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 20.0 | BCD110605C49 | 1.51 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 20.0 | BCD110605C51 | 4.19 | pmol/ml of medium |
| - | PGA2 | KDO+PLDi | 20.0 | BCD110605C50 | 3.95 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 1.0 | BCD110605C07 | 0.169 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 1.0 | BCD110605C09 | 0.199 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 1.0 | BCD110605C08 | 0.233 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 4.0 | BCD110605C25 | 0.655 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 4.0 | BCD110605C26 | 0.613 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 4.0 | BCD110605C27 | 0.5 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 20.0 | BCD110605C45 | 3.97 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 20.0 | BCD110605C43 | 3.07 | pmol/ml of medium |
| - | PGA2 | KDO + ATP | 20.0 | BCD110605C44 | 2.79 | pmol/ml of medium |
| - | PGA2 | C | 0.0 | BCD110605C02 | 0.058 | pmol/ml of medium |
| - | PGA2 | C | 0.0 | BCD110605C01 | 0.032 | pmol/ml of medium |
| - | PGA2 | C | 0.0 | BCD110605C03 | 0.049 | pmol/ml of medium |
| - | PGA2 | C | 1.0 | BCD110605C06 | 0.023 | pmol/ml of medium |
| - | PGA2 | C | 1.0 | BCD110605C05 | 0.024 | pmol/ml of medium |